State‑Dependent Immune Targeting in Chronic Viral Infection

Read full text
Authors: Shokoofeh MOHAMMADIGHEITASABADI
Cited by: 0

Abstract

This work presents a conceptual and theoretical framework proposing a novel approach to the treatment of chronic viral infections by shifting immune targeting from mutable viral structures to persistent functional states of infected host cells. Conventional antiviral and immunological strategies primarily focus on identifying viral antigens. However, chronic viruses evade immune clearance through rapid mutation and immune tolerance. This framework hypothesizes that while viral structures are highly variable, the cellular states required for sustained viral replication are energetically costly, persistent, and fundamentally unavoidable.The proposed model introduces State‑Dependent Immune Targeting, in which immune recognition and elimination are guided by a combination of: * Persistent electrical membrane alterations associated with chronic cellular stress * Metabolic and enzymatic stress signatures intrinsic to active viral replication * Temporal persistence of stress, distinguishing chronic infection from transient inflammation Rather than attempting complete viral eradication, the framework emphasizes early elimination of infected cells prior to effective viral release, thereby disrupting the viral replication cycle by reducing its effective reproductive capacity. A conceptual multi‑layer architecture is outlined, consisting of: 1- A physical or electrical bias layer for preferential targeting 2- A biochemical confirmation layer to ensure specificity 3-A temporal integration layer to prevent off‑target immune damage This framework is theoretical and hypothesis‑driven, intended to stimulate interdisciplinary research across immunology, virology, biophysics, and systems biology. It does not propose a specific therapeutic agent but provides a foundational logic for future experimental and translational work.

Fields of Study & Subjects

interferon and immune responses HIV Research and Treatment Immune Response and Inflammation

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
12 February 2026
Language
EN